These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 38429252)

  • 1. Association of LDL-cholesterol <1.8 mmol/L and statin use with the recurrence of intracerebral hemorrhage.
    Lee TC; Leung WC; Ho C; Chiu MW; Leung IY; Wong YK; Roxanna LK; Sum CH; Lui DT; Cheung RT; Leung GK; Chan KH; Teo KC; Lau KK
    Int J Stroke; 2024 Jul; 19(6):695-704. PubMed ID: 38429252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of prestroke statin use and lipid levels with outcome of intracerebral hemorrhage.
    Mustanoja S; Strbian D; Putaala J; Meretoja A; Curtze S; Haapaniemi E; Sairanen T; Hietikko R; Sirén J; Kaste M; Tatlisumak T
    Stroke; 2013 Aug; 44(8):2330-2. PubMed ID: 23760210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of Statin Therapy on the Risk of Intracerebral Hemorrhage in Korean Patients with Hyperlipidemia.
    Jung M; Lee S
    Pharmacotherapy; 2019 Feb; 39(2):129-139. PubMed ID: 30585646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Higher low-density lipoprotein cholesterol levels are associated with decreased mortality in patients with intracerebral hemorrhage.
    Chang JJ; Katsanos AH; Khorchid Y; Dillard K; Kerro A; Burgess LG; Goyal N; Alexandrov AW; Alexandrov AV; Tsivgoulis G
    Atherosclerosis; 2018 Feb; 269():14-20. PubMed ID: 29253643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Statin use after intracerebral hemorrhage: a 10-year nationwide cohort study.
    Tai SY; Lin FC; Lee CY; Chang CJ; Wu MT; Chien CY
    Brain Behav; 2016 Aug; 6(8):e00487. PubMed ID: 27247857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lower low-density lipoprotein cholesterol levels are associated with an increased risk of hematoma expansion and ensuing mortality in acute ICH patients.
    Wang Y; Wu J; Gu H; Yang K; Jiang R; Li Z; Zhao X; Wang Y;
    Neurol Sci; 2022 May; 43(5):3121-3129. PubMed ID: 34806117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinicoradiological profile and serum lipid levels of intracerebral hemorrhage in prior statin users.
    Miura K; Yoshii Y; Nakamura Y; Ikeda K
    Intern Med; 2011; 50(13):1385-91. PubMed ID: 21720057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of previous statin use on first intracerebral hemorrhage in cerebral amyloid angiopathy.
    Helven C; Burel J; Vannier M; Maltête D; Ozkul-Wermester O; Hermary C; Wallon D; Grangeon L
    Rev Neurol (Paris); 2023 Dec; 179(10):1074-1080. PubMed ID: 37598087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Statin use and microbleeds in patients with spontaneous intracerebral hemorrhage.
    Haussen DC; Henninger N; Kumar S; Selim M
    Stroke; 2012 Oct; 43(10):2677-81. PubMed ID: 22829545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of Statin Use With Risk of Stroke Recurrence After Intracerebral Hemorrhage.
    Gaist D; García Rodríguez LA; Hallas J; Hald SM; Möller S; Høyer BB; Selim M; Goldstein LB
    Neurology; 2023 Oct; 101(18):e1793-e1806. PubMed ID: 37648526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of statins on intracerebral hemorrhage outcome and recurrence.
    FitzMaurice E; Wendell L; Snider R; Schwab K; Chanderraj R; Kinnecom C; Nandigam K; Rost NS; Viswanathan A; Rosand J; Greenberg SM; Smith EE
    Stroke; 2008 Jul; 39(7):2151-4. PubMed ID: 18436876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cortical superficial siderosis and recurrent intracerebral hemorrhage risk in cerebral amyloid angiopathy: Large prospective cohort and preliminary meta-analysis.
    Charidimou A; Boulouis G; Roongpiboonsopit D; Xiong L; Pasi M; Schwab KM; Rosand J; Gurol ME; Greenberg SM; Viswanathan A
    Int J Stroke; 2019 Oct; 14(7):723-733. PubMed ID: 30785378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of statin use and lipid levels with cerebral microbleeds and intracranial hemorrhage in patients with atrial fibrillation: A prospective cohort study.
    Moutzouri E; Glutz M; Abolhassani N; Feller M; Adam L; Gencer B; Del Giovane C; Bétrisey S; Paladini RE; Hennings E; Aeschbacher S; Beer JH; Moschovitis G; Seiffge D; De Marchis GM; Coslovsky M; Reichlin T; Conte G; Sinnecker T; Schwenkglenks M; Bonati LH; Kastner P; Aujesky D; Kühne M; Osswald S; Fischer U; Conen D; Rodondi N
    Int J Stroke; 2023 Dec; 18(10):1219-1227. PubMed ID: 37243540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association Between Intensity of Low-Density Lipoprotein Cholesterol Reduction With Statin-Based Therapies and Secondary Stroke Prevention: A Meta-analysis of Randomized Clinical Trials.
    Lee M; Cheng CY; Wu YL; Lee JD; Hsu CY; Ovbiagele B
    JAMA Neurol; 2022 Apr; 79(4):349-358. PubMed ID: 35188949
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characteristics of subjects with very low serum low-density lipoprotein cholesterol and the risk for intracerebral hemorrhage.
    Lee JG; Koh SJ; Yoo SY; Yu JR; Lee SA; Koh G; Lee D
    Korean J Intern Med; 2012 Sep; 27(3):317-26. PubMed ID: 23019397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low LDL cholesterol, albuminuria, and statins for the risk of cancer in type 2 diabetes: the Hong Kong diabetes registry.
    Yang X; So WY; Ma RC; Ko GT; Kong AP; Zhao H; Luk AO; Lam CW; Ho CS; Tong PC; Chan JC
    Diabetes Care; 2009 Oct; 32(10):1826-32. PubMed ID: 19592629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early statin therapy in patients with acute intracerebral hemorrhage without prior statin use.
    Chen PS; Cheng CL; Chang YC; Kao Yang YH; Yeh PS; Li YH
    Eur J Neurol; 2015 May; 22(5):773-80. PubMed ID: 25623473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of initiating statin therapy on long-term outcomes of patients with dyslipidemia after intracerebral hemorrhage.
    Lin MS; Lin YS; Chang ST; Wang PC; Chien-Chia Wu V; Lin WY; Chung CM
    Atherosclerosis; 2019 Sep; 288():137-145. PubMed ID: 31374467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Limitations of real-world treatment with atorvastatin monotherapy for lowering LDL-C in high-risk cardiovascular patients in the US.
    Marrett E; Zhao C; Zhang NJ; Zhang Q; Ramey DR; Tomassini JE; Tershakovec AM; Neff DR
    Vasc Health Risk Manag; 2014; 10():237-46. PubMed ID: 24851051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dose-related effects of statins on symptomatic intracerebral hemorrhage and outcome after thrombolysis for ischemic stroke.
    Scheitz JF; Seiffge DJ; Tütüncü S; Gensicke H; Audebert HJ; Bonati LH; Fiebach JB; Tränka C; Lyrer PA; Endres M; Engelter ST; Nolte CH
    Stroke; 2014 Feb; 45(2):509-14. PubMed ID: 24368561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.